Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI

Abstract To analyze the clinical characteristics of patients with negative biparametric magnetic resonance imaging (bpMRI) who didn’t need prostate biopsies (PBs). A total of 1,012 male patients who underwent PBs in the First Affiliated Hospital of Nanjing Medical University from March 2018 to Novem...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Linghui Liang, Feng Qi, Yifei Cheng, Lei Zhang, Dongliang Cao, Gong Cheng, Lixin Hua
Formato:	article
Lenguaje:	EN
Publicado:	Nature Portfolio 2021
Materias:	Medicine R Science Q
Acceso en línea:	https://doaj.org/article/383f3b67478d467199132c387407bc5e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:383f3b67478d467199132c387407bc5e
record_format	dspace
spelling	oai:doaj.org-article:383f3b67478d467199132c387407bc5e2021-12-02T11:39:48ZAnalysis of risk factors for determining the need for prostate biopsy in patients with negative MRI10.1038/s41598-021-83802-z2045-2322https://doaj.org/article/383f3b67478d467199132c387407bc5e2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83802-zhttps://doaj.org/toc/2045-2322Abstract To analyze the clinical characteristics of patients with negative biparametric magnetic resonance imaging (bpMRI) who didn’t need prostate biopsies (PBs). A total of 1,012 male patients who underwent PBs in the First Affiliated Hospital of Nanjing Medical University from March 2018 to November 2019, of 225 had prebiopsy negative bpMRI (defined as Prostate Imaging Reporting and Data System (PI-RADS 2.1) score less than 3). The detection efficiency of clinically significant prostate cancer (CSPCa) was assessed according to age, digital rectal examination (DRE), prostate volume (PV) on bpMRI, prostate-specific antigen (PSA) and PSA density (PSAD). The definition of CSPCa for Gleason score > 6. Univariate and multivariable logistic regression analysis were used to identify predictive factors of absent CSPCa on PBs. Moreover, absent CSPCa contained clinically insignificant prostate cancer (CIPCa) and benign result. The detection rates of present prostate cancer (PCa) and CSPCa were 27.11% and 16.44%, respectively. Patients who were diagnosed as CSPCa had an older age (P < 0.001), suspicious DRE (P < 0.001), a smaller PV (P < 0.001), higher PSA value (P = 0.008) and higher PSAD (P < 0.001) compared to the CIPCa group and benign result group. PSAD < 0.15 ng/ml/cm3 (P = 0.004) and suspicious DRE (P < 0.001) were independent predictors of absent CSPCa on BPs. The negative forecast value of bpMRI for BP detection of CSPCa increased with decreasing PSAD, mainly in patients with naive PB (P < 0.001) but not in prior negative PB patients. 25.33% of the men had the combination of negative bpMRI, PSAD < 0.15 ng/ml/cm3 and PB naive, and none had CSPCa on repeat PBs. The incidence of PB was determined, CSPCa was 1.59%, 0% and 16.67% in patients with negative bpMRI and PSAD < 0.15 ng/ml/cm3, patients with negative bpMRI, PSAD < 0.15 ng/ml/cm3 and biopsy naive and patients with negative bpMRI, PSAD < 0.15 ng/ml/cm3 and prior negative PB, separately. We found that a part of patients with negative bpMRI, a younger age, no suspicious DRE and PSAD < 0.15 ng/ml/cm3 may securely avoid PBs. Conversely PB should be considered in patients regardless of negative bpMRI, especially who with a greater age, obviously suspicious DRE, significantly increased PSA value, a significantly small PV on MRI and PSAD > 0.15 ng/ml/cm3.Linghui LiangFeng QiYifei ChengLei ZhangDongliang CaoGong ChengLixin HuaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Medicine R Science Q
spellingShingle	Medicine R Science Q Linghui Liang Feng Qi Yifei Cheng Lei Zhang Dongliang Cao Gong Cheng Lixin Hua Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
description	Abstract To analyze the clinical characteristics of patients with negative biparametric magnetic resonance imaging (bpMRI) who didn’t need prostate biopsies (PBs). A total of 1,012 male patients who underwent PBs in the First Affiliated Hospital of Nanjing Medical University from March 2018 to November 2019, of 225 had prebiopsy negative bpMRI (defined as Prostate Imaging Reporting and Data System (PI-RADS 2.1) score less than 3). The detection efficiency of clinically significant prostate cancer (CSPCa) was assessed according to age, digital rectal examination (DRE), prostate volume (PV) on bpMRI, prostate-specific antigen (PSA) and PSA density (PSAD). The definition of CSPCa for Gleason score > 6. Univariate and multivariable logistic regression analysis were used to identify predictive factors of absent CSPCa on PBs. Moreover, absent CSPCa contained clinically insignificant prostate cancer (CIPCa) and benign result. The detection rates of present prostate cancer (PCa) and CSPCa were 27.11% and 16.44%, respectively. Patients who were diagnosed as CSPCa had an older age (P < 0.001), suspicious DRE (P < 0.001), a smaller PV (P < 0.001), higher PSA value (P = 0.008) and higher PSAD (P < 0.001) compared to the CIPCa group and benign result group. PSAD < 0.15 ng/ml/cm3 (P = 0.004) and suspicious DRE (P < 0.001) were independent predictors of absent CSPCa on BPs. The negative forecast value of bpMRI for BP detection of CSPCa increased with decreasing PSAD, mainly in patients with naive PB (P < 0.001) but not in prior negative PB patients. 25.33% of the men had the combination of negative bpMRI, PSAD < 0.15 ng/ml/cm3 and PB naive, and none had CSPCa on repeat PBs. The incidence of PB was determined, CSPCa was 1.59%, 0% and 16.67% in patients with negative bpMRI and PSAD < 0.15 ng/ml/cm3, patients with negative bpMRI, PSAD < 0.15 ng/ml/cm3 and biopsy naive and patients with negative bpMRI, PSAD < 0.15 ng/ml/cm3 and prior negative PB, separately. We found that a part of patients with negative bpMRI, a younger age, no suspicious DRE and PSAD < 0.15 ng/ml/cm3 may securely avoid PBs. Conversely PB should be considered in patients regardless of negative bpMRI, especially who with a greater age, obviously suspicious DRE, significantly increased PSA value, a significantly small PV on MRI and PSAD > 0.15 ng/ml/cm3.
format	article
author	Linghui Liang Feng Qi Yifei Cheng Lei Zhang Dongliang Cao Gong Cheng Lixin Hua
author_facet	Linghui Liang Feng Qi Yifei Cheng Lei Zhang Dongliang Cao Gong Cheng Lixin Hua
author_sort	Linghui Liang
title	Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
title_short	Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
title_full	Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
title_fullStr	Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
title_full_unstemmed	Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI
title_sort	analysis of risk factors for determining the need for prostate biopsy in patients with negative mri
publisher	Nature Portfolio
publishDate	2021
url	https://doaj.org/article/383f3b67478d467199132c387407bc5e
work_keys_str_mv	AT linghuiliang analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT fengqi analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT yifeicheng analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT leizhang analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT dongliangcao analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT gongcheng analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri AT lixinhua analysisofriskfactorsfordeterminingtheneedforprostatebiopsyinpatientswithnegativemri
_version_	1718395694860992512

Analysis of risk factors for determining the need for prostate biopsy in patients with negative MRI

Ejemplares similares